Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

A woman's hands star in a Lilly spot, shown playing key role in activities like gardening -- and discovering a lump in her ...

ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...

Birmingham is suing drug manufacturers and health companies, alleging they worked together to establish an “insulin pricing scheme” and inflate the cost of life-saving medicine.

The Alzheimer’s Association advised against diagnosing the disease on biomarkers alone, but other experts said the genie ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

In the latest trading session, Eli Lilly (LLY) closed at $753.98 ... Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Eli Lilly (LLY) ended the recent trading session ... Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this ...